- Home
- BCCQ vs CLLS Comparison
BCCQ vs CLLS Comparison
Compare BCCQ & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$1.51
Company Overview
Basic Information| Metric | BCCQ | CLLS |
|---|---|---|
| Founded | N/A | 1999 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 409.9M | 394.4M |
| IPO Year | 2026 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BCCQ | CLLS |
|---|---|---|
| Price | $9.98 | $1.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.33 |
| AVG Volume (30 Days) | ★ 303.5K | 159.8K |
| Earning Date | N/A | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.98 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.71 | $1.25 |
| 52 Week High | $10.12 | $5.48 |
Technical Indicators
Market Signals| Indicator | BCCQ | CLLS |
|---|---|---|
| Relative Strength Index (RSI) | 61.36 | 22.61 |
| Support Level | $9.71 | N/A |
| Resistance Level | $10.05 | $3.47 |
| Average True Range (ATR) | 0.03 | 0.21 |
| MACD | -0.01 | -0.20 |
| Stochastic Oscillator | 25.37 | 11.57 |
Price Performance
Historical Comparison BCCQ
CLLS
About BCCQ Bleichroeder Acquisition Corp. III Class A Ordinary Shares
Bleichroeder Acquisition Corp III is a blank check company.
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.